Ahmedabad-based Torrent Pharma commissioned a new facility to manufacture 26 mn vials a year of human insulin.
Global major Novo Nordisk will send insulin crystals to Torrent Pharma, which will then process it into Novo Nordisk Insulin. Torrent Pharma has been the sole manufacturer of insulin for Novo Nordisk since the early nineties.
India has the largest number of diabetes patients in the world at 50 mn, which will rise to 80 mn by 2025. Torrent’s new facility will provide a world class product at affordable prices to Indian customers, says Novo Nordisk.